Impact News +++ Precision BioSciences gets FDA rare disease status for DMD treatment, stock jumps 10% (SeekingAlpha) +++ PRECISION BIOSCIENCES Aktie +3,56%

SOLVAY ADR Aktie

>SOLVAY ADR Performance

1 Woche: 0%

1 Monat: -2,8%

3 Monate: -12,0%

6 Monate: -5,4%

1 Jahr: -6,7%

laufendes Jahr: -4,8%

>SOLVAY ADR Aktie

Name:

SOLVAY S.A. UNSP.ADR/1/10

Land:

USA

Sektor:

Chemie

ISIN/ Wkn:

US8344374025 / A3DE5S

Symbol/ Ticker:

SOL0 (Frankfurt)

Kürzel:

FRA:SOL0, ETR:SOL0, SOL0:GR

Index:

Webseite:

https://www.solvay.com/

Marktkapitalisierung:

3110 Mio. EUR

Umsatz:

4390.52 Mio. EUR

EBITDA:

683.26 Mio. EUR

Gewinn je Aktie:

0.165 EUR

Schulden:

1922.48 Mio. EUR

Liquide Mittel:

404.41 Mio. EUR

Umsatz-/ Gewinnwachstum:

-4.2% / -24.3%

KGV/ KGV lG:

15.05 / 7.14

KUV/ KBV/ PEG:

0.58 / 2.15 / -

Gewinnm./ Eigenkapitalr.:

3.88% / 14.16%

Dividende je Aktie:

0.094 EUR

Dividendenrendite/ -schätzung:

3.4% / 10.33%

Div. Historie:

27.01.25 - 0.09443€
03.06.24 - 0.0409€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

SOLVAY ADR, SOLVAY

Letzte Datenerhebung:

25.06.25

>SOLVAY ADR Eigentümer

Aktien: 1040 Mio. St.

f.h. Aktien: 65.47 Mio. St.

Insider Eigner: -

Instit. Eigner: -

Leerverk. Aktien: -

>SOLVAY ADR Anleihen

Es sind 4 Anleihen zur SOLVAY ADR Aktie bekannt.

>SOLVAY ADR Peer Group

ADVANSIX

AVANTOR

ELEMENT SOLUTIONS

FMC CORPORATION

GEVO

HAWKINS INC

HUNTSMAN

MINERALS TECHNOLOGIES

RPM INTERNATIONAL

QUIMICA

>SOLVAY ADR Chart & Kurs - Stuttgart

>SOLVAY ADR News

26.05.25 - 23:51	XFRA: DIVIDEND/INTEREST INFORMATION - 27.05.2025 - EQUBF_01 (XETRA)
	Das Instrument SOL0 US8344374025 SOLVAY S.A. UNSP.ADR/1/10 EQUITY wird ex Dividende/Zinsen gehandelt am 27.05.2025 The instrument SOL0 US8344374025 SOLVAY S.A. UNSP.ADR/1/10 EQUITY has its ex-dividend/interest day on 27.05.2025...

08.05.25 - 12:24	Solvay shares tumble as company narrows core profit outlook on tariff threats (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

08.05.25 - 12:24	Basic Materials Roundup: Market Talk (WSJ EN)
	Find insight on Mondi, Solvay and more in the latest Market Talks covering Basic Materials....

08.05.25 - 07:03	Solvay first quarter 2025 results (GlobeNewswire EN)
	Resilient performance supported by a diversified portfolio and cost savings...

10.04.25 - 18:03	Solvay publishes notice of 2025 Annual General Meeting (GlobeNewswire EN)
	Brussels, April 10, 2025, 6:00pm CEST – Regulated information...

08.04.25 - 10:42	Solvay to launch Europe′s first rare earths processing plant (Nikkei)
	Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...

03.04.25 - 18:03	Solvay releases its 2024 annual integrated report (GlobeNewswire EN)
	In 2024, Solvay introduced its “Essential for generations” strategy, delivered solid performance and launched the “For Generations” sustainability roadmap...

13.03.25 - 18:03	Solvay: acquisition of own shares (GlobeNewswire EN)
	Press release - Regulated information ...

06.03.25 - 14:54	Solvay reports FY results (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

06.03.25 - 12:24	Basic Materials Roundup: Market Talk (WSJ EN)
	Find insight on Solvay, Evonik and more in the latest Market Talks covering Basic Materials....

06.03.25 - 07:03	Solvay fourth quarter and full year 2024 results (GlobeNewswire EN)
	Solid EBITDA and free cash flow supported by cost savings acceleration...

26.01.25 - 21:39	XFRA : DIVIDEND/INTEREST INFORMATION - 27.01.2025 - US8344374025 (XETRA)
	Das Instrument SOL0 US8344374025 SOLVAY S.A. UNSP.ADR/1/10 EQUITY wird ex Dividende/Zinsen gehandelt am 27.01.2025 The instrument SOL0 US8344374025 SOLVAY S.A. UNSP.ADR/1/10 EQUITY has its ex-dividend/interest day on 27.01.2025...

23.01.25 - 23:54	XFRA : DIVIDEND/INTEREST INFORMATION - 27.01.2025 - US8344374025 (XETRA)
	Das Instrument SOL0 US8344374025 SOLVAY S.A. UNSP.ADR/1/10 EQUITY wird cum Dividende/Zinsen gehandelt am 24.01.2025 und ex Dividende/Zinsen am 27.01.2025 The instrument SOL0 US8344374025 SOLVAY S.A. UNSP.ADR/1/10 EQUITY has its pre-dividend/interest day on 24.01.2025 and its ex-dividend/interest day on 27.01.2025...

17.12.24 - 17:48	Solvay Financial Calendar 2025 (GlobeNewswire EN)
	Solvay 2025 Financial Calendar...

17.12.24 - 12:42	We are seeing continuous improvement through the use of machine learning, Solvay CEO says (CNBC)
	Jean-Marc Ollagnier, chairman of EMEA at Accenture, and Solvay CEO Philippe Kehren discuss the interplay between AI and decarbonization....

21.11.24 - 12:06	Solvay achieves 100% renewable energy at Rheinberg with second biomass boiler, reducing CO2 emissions by 65% (GlobeNewswire EN)
	Brussels, November 21, 2024 ...

06.11.24 - 15:57	Solvay reports Q3 results (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

06.11.24 - 07:03	Solvay third quarter 2024 results (GlobeNewswire EN)
	Press release - Regulated information published on November 6, 2024, at 7:00 a.m. CET...

24.10.24 - 13:33

Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer (GlobeNewswire EN)

NEW YORK and MELBOURNE, Australia, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex), a clinical-stage biopharmaceutical company developing innovative medicines for people with chronic diseases and significant unmet medical needs, today announced the appointment of Lou Barbato, M.D., as Chief Medical Officer (CMO) effective immediately. Dr. Barbato's drug development experience includes senior clinical development and operational roles at Jazz Pharmaceuticals, AbbVie, Biogen, Novartis, and Solvay. He joins Incannex as the company continues to advance its lead clinical-stage programs in obstructive sleep apnea, generalized anxiety disorder, and rheumatoid arthritis....

10.10.24 - 10:06	Solvay completes its largest GHG emissions reduction project yet, transforming U.S. Green River operations (GlobeNewswire EN)
	Green River, Wyoming, USA, October 10, 2024...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Wer das Recht mit Füßen tritt, steht selten fest auf den Beinen. - Stanislaw Jerzy Lec

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram